Growth hormone
Tesamorelin
Clinically approved
4.30 reviewsPrimary purposes
Fat loss, Visceral fat reduction
Relevant conditions
HIV lipodystrophy, Abdominal obesity
Mechanism of action
Stabilized GHRH analog that stimulates pituitary GH release.
Details
Tesamorelin (Egrifta) is FDA-approved to reduce abdominal fat in HIV lipodystrophy. Trials also suggest benefits for liver fat.
Verified sources & manufacturers
Coming soon – we are building a list of verified studies and manufacturers. Learn more
Community experiences
Sign in to write reviews and share experiences.
No reviews yet – be the first.